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ABSTRACT 
 
Rationale: Despite increasing understanding of the prognostic importance of vascular stiffening linked to 
perivascular fibrosis in hypertension, the molecular and cellular regulation of this process is poorly  
understood.  
 
Objectives: To study the functional role of microRNA-214 (miR-214) in the induction of perivascular 
fibrosis and endothelial dysfunction driving vascular stiffening.   
 
Methods and Results: Out of 381 miRs screened in the perivascular tissues (PVAT) in response to 
angiotensin II (Ang II)-mediated hypertension, miR-214 showed the highest induction (8-fold, p=0.0001). 
MiR-214 induction was pronounced in perivascular and circulating T cells, but not in PVAT adipocytes. 
Global deletion of miR-214-/- prevented Ang II-induced periaortic fibrosis Col1a1, Col3a1, Col5a1 and 
Tgfb1 expression, hydroxyproline accumulation and vascular stiffening, without difference in blood 
pressure. Mechanistic studies revealed that miR-214-/- mice were protected against endothelial dysfunction, 
oxidative stress and increased Nox2, all of which were induced by Ang II in WT mice. Ang II-induced 
recruitment of T cells into PVAT was abolished in miR-214-/- mice. Adoptive transfer of miR-214-/- T cells 
into RAG1-/- mice resulted in reduced perivascular fibrosis compared to the effect of WT T cells.  
Ang II induced hypertension caused significant change in the expression of 1380  
T cell genes in WT, but only 51 in miR-214-/-. T cell activation, proliferation and chemotaxis pathways 
were differentially affected. miR-214-/- prevented Ang II-induction of pro-fibrotic T cell cytokines (IL-17, 
TNF-, IL-9 and IFN-and chemokine receptors (CCR1, CCR2, CCR4, CCR5, CCR6 and CXCR3). This 
manifested in reduced in vitro and in vivo T cell chemotaxis resulting in attenuation of profibrotic 
perivascular inflammation. Translationally, we show that miR-214 is increased in plasma of hypertensive 
patients and is directly correlated to pulse wave velocity as a measure of vascular stiffness.   
 
Conclusions: T cell-derived miR-214 controls pathological perivascular fibrosis in hypertension mediated 
by T cell recruitment and local profibrotic cytokine release. 
 
Keywords:  
miR-214, vascular oxidative stress, endothelial dysfunction, blood pressure, fibrosis, collagen, 
perivascular fat, inflammation, T-cell.  
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Nonstandard Abbreviations and Acronyms: 
 
miR   microRNA 
PVAT   perivascular adipose tissue 
Ang II    angiotensin II  
CCL5 (RANTES)  C-C motif chemokine ligand 5 (Regulated on Activation, Normal T-cell Expressed 
and Secreted) 
CCR C-C chemokine receptor  
TNF-   tumour necrosis alpha 
IFN-   interferon gamma  
IL   interleukin  
Tgfb1   transforming growth factor beta (TGF-)  
PWV   pulse wave velocity 
FMD   flow mediated dilatation 
eNOS   endothelial Nitric oxide synthases 
NADPH   nicotinamide adenine dinucleotide phosphate  
VSMCs  vascular smooth muscle cells  
RAG1   recombination activating gene 
 
 
 
INTRODUCTION 
 
Hypertension continues to be the number one cause of death and disability worldwide1. While blood 
pressure reduction improves disease outcomes, cardiovascular risk remains highly elevated indicating that 
underlying pathological processes are essential in mediating adverse clinical outcomes. Accelerated 
vascular ageing a hallmark of hypertension underlies all of the target organ consequences of the disease2. 
It encompasses a number of pathophysiologic processes including increased vascular oxidative stress, 
increased perivascular inflammation, endothelial dysfunction, all leading collectively to augmentation of 
vascular stiffening mediated primarily by perivascular fibrosis3-6.  Vascular stiffening, measured by pulse 
wave velocity (PWV) is uniformly accepted as an important predictor of cardiovascular morbidity and 
mortality1, 7. Therefore, understanding the molecular mechanisms of vascular stiffening is essential for 
development of novel therapies which can to reduce cardiovascular risk in hypertension. Inflammation has 
been one of the important common denominators of cardiovascular risk8 and arterial stiffness9 and immune 
cell infiltration is pivotal for perivascular fibrosis6, 10-12.  
 
While the opposing effects of miR-214 have been recently defined in cardiac13, 14 and renal15, 16 
fibrosis, the expression and function of miR-214 in vascular fibrosis and stiffening remains unknown. 
Perivascular fibrosis is largely dependent on perivascular inflammation6. Notably, miR-214 is expressed by 
immune cells and affects their functions as indicated by studies of tumor immunity17 including possible 
regulation of profibrotic cytokines, such as TGF-  or IL-1718. This is important as IL-17-mediated vascular 
stiffening can occur through increasing the deposition of collagen10.  
 
We sought to examine mechanisms responsible for aortic stiffening in hypertension focusing on 
the role of microRNAs in the regulation of vascular fibrosis. Recent studies have shown that perivascular 
inflammation regulates vascular dysfunction and remodeling in hypertension10, 19. Here, we have identified 
that miR-214 is increased in perivascular adipose tissue (PVAT) in hypertension, and that this increase is 
observed primarily in T cells infiltrating the vessel. MiR-214 expression in T cells enables their activation 
and recruitment into perivascular fat in the context of hypertension. It also regulates T cell pro-fibrotic 
properties in response to pro-hypertensive stimuli. Translational relevance of these findings has been 
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confirmed by the fact that plasma miR-214 is increased in hypertension and is directly correlated to pulse 
wave velocity and endothelial function.  
 
 
 
METHODS 
 
The data that support the findings of this study are available from the first and corresponding authors upon 
reasonable request. 
 
The hypertension and perivascular inflammation studies have been conducted as described previously19, 20. 
Hypertension was induced in twelve-week old male mice by infusion of angiotensin II (490ng/kg/d) for 14 
days via osmotic minipumps (Model 2002, Alzet Corporation). Male mice were used as this is best validated 
model for hypertension, particularly in the context of T cell immune responses. C57BL/6 and Rag1-/- 
(B6.129S7-Rag1tm1Mom/J) were obtained from Jackson Laboratories. The miR-214-/- mice were kindly 
gifted by Dr Eric Olson previously described which for adoptive transfer experiments were backcrossed 7 
times to C57BL/6N background. All animal experiments were performed in accordance with the United 
Kingdom Animals Scientific Procedures Act 1986 and ARRIVE (Animal Research: Reporting of In Vivo 
Experiments) Guidelines and approved by the Home Office and ethics committee of Jagiellonian University 
(157/2016). All experiments conform the guidelines from Directive 2010/63/EU of the European 
Parliament on the protection of animals used for scientific purposes. Randomization and allocation 
concealment were performed. Kolmogorov-Smirnov test, Shapiro-Wilk, q-q-plots and histograms were 
used to test normality of data distribution before parametric or non-parametric tests were applied. 
Correlation between cells was assessed by Spearman’s rank correlation analysis. Statistical analysis was 
performed using t-test (2-group studies), one-way or two-way ANOVA (>2-group studies) with a Tukey’s 
multiple comparison test,  Kruskal-Wallis test or Mann-Whitney U test.  Data are reported as the 
meanstandard mean error (SEM). P values <0.05 were considered significant. Reported p values include 
multiple comparison correction (Bonferroni or FDR). Number of samples is given in individual Figure 
legends and represent biological replicates (mice used for experiments). Data based on tail cuff experiments 
indicate that to detect SBP change from 123 to 143 mmHg, 8 mice/group are needed to detect significant 
(p<0.05) difference at a power of 80%. Differential gene expression analysis from the RNA-Seq experiment 
was performed using DESeq2 package in R (ver. 3.5.1). Raw gene counts of the RNA-Seq analysis are 
available as supplemental material. RNA-Seq datasets are deposited in the Gene Expression Omnibus 
(GEO)-accession number GSE143809 database. 
 
Translational study was performed on 51 hypertensive and 49 normotensive subjects (Clinical 
Characteristics – Online Table I) and included analysis of miR-214 in plasma, pulse wave velocity (PWV) 
and flow mediated dilatation (FMD) studies as described previuosly19, 21. Study was performed according 
to the Declaration of Helsinki and was approved by the Ethics Committee of Jagiellonian University. All 
participants gave written informed consent.  
 
Analysis in patient populations were performed in Statistica 13 TIBCO using t test for independent samples. 
Correlation between PWV and plasma miR-214 was assessed by Spearman’s rank correlation test and then 
by multiple regression correcting for SBP and age..  
 
A detailed Materials and Methods section is provided in the Online Supplemental Material. 
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RESULTS 
 
miR-214 is increased in the vasculature in Ang II-induced hypertension.  
 
To identify microRNAs potentially important in the regulation of perivascular inflammation and 
dysfunction in hypertension, we performed a TaqMan array analysis in perivascular tissue of sham- and 
Ang II-infused mice. Principal component analysis comprising miR transcripts detected a notable 
separation of sample sets (Figure 1A, top). Of 381assayed microRNAs, 134 showed expression below 35th 
Ct value. 28 showed differential expression (Figure 1A-B). 15 were significantly upregulated and 13 were 
downregulated (Figure 1B). miR-214 was the only over-expressed microRNA significantly altered after 
Bonferroni correction showing an 8-fold increase (Figure 1A-B), which was not observed in other members 
of miR-199/214 cluster (Figure 1C, top). Similar, although less pronounced an increase was observed in 
the pri-miR-214 transcript (Figure 1C, bottom). In situ hybridization (Figure 1D) and RT-PCR (Figure 1E) 
was used to visualize and quantify the induction of miR-214 in different areas of the vessel. MiR-214 was 
increased nearly 8-fold in PVAT and only 2-fold in other vessel layers. Surprisingly no increase was 
observed in primary adipocytes isolated from PVAT of Ang II-treated vs sham mice (Online Figure I). 
Subsequent interrogation of the effects of Ang II on miR-214 expression in kidneys, peripheral blood 
mononuclear cells (PBMC), spleen and lymph nodes demonstrated its pronounced increase in the spleen 
and PBMCs (Figure 1E).  
 
To investigate if the miR-214 increase in the PVAT was evoked by the direct actions of Ang II or 
indirectly by blood pressure elevation we used the model of pre-treatment of mice with oral hydralazine 
(Hyd) and hydrochlorothiazide (HCT)11, which reduced blood pressure in spite of Ang II infusion from 
165±5 mmHg (placebo; Ang II) to 133±6 mmHg (Hyd/HCT; Ang II) (Online Figure II). The increase in 
PVAT miR-214 (left) and pri-miR-214 (right) was abolished in Hyd/HCT mice in spite of Ang II infusion 
(Fig 1F). 
 
miR-214-/- protects from hypertension induced vascular stiffness and perivascular fibrosis. 
 
In order to understand the functional role of miR-214 in hypertension we used miR-214-/- mice in 
which we investigated development of hypertension, as well as vascular dysfunction and remodeling. In 
vivo, miR-214-/- mice did not show altered blood pressures either at baseline or throughout 14-day Ang II 
infusion evaluated by both tail cuff (Figure 2A) and telemetry (Figure 2B). Importantly, in spite of that, we 
observed a significant reduction in periaortic collagen accumulation/fibrosis in miR-214-/- mice using 
Picrosirius red and Masson’s trichrome staining (Figure 2C and D). In wild type mice, aortic Col1a1, 
Col3a1 and Col5a1 were all significantly induced by Ang II but this increase was abolished in miR-214-/- 
mice (Figure 2E). Furthermore, hydroxyproline accumulation was observed in the aortas of Ang II infused 
WT but not miR-214-/- mice (Figure 2F).  
 
Functional consequences of perivascular fibrosis were studied using assessment of vascular 
stiffness. MiR-214-/- mice were protected from the development of hypertensive vascular stiffening in 
pressure myography in mouse aortas including adventitial layer (Figure 3A). Nanoindentation studies 
utilizing atomic force microscopy also showed an increase of Young’s modulus of the aortic wall in wild 
type mice with Ang II infusion, while this increase was abolished in miR-214-/- mice (Figure 3B).  
 
miR-214 is associated with vascular stiffness in human hypertension. 
 
To assess translational relevance of these observations to human hypertension, we investigated 
plasma miR-214 levels in patients with and without hypertension (for detailed clinical characteristics please 
see Online Table I), and in relation to pulse wave velocity, as a measure of vascular stiffness7. MiR-214 
levels were higher in patients with hypertension (Figure 3C). Notably, there was a significant correlation 
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between plasma miR-214 levels and pulse wave velocity (Figure 3D). This relationship remained 
significant in multiple regression analysis after correcting for blood pressure and age (miR-214/PWV: 
Beta*=0.212; p=0.02). No significant relationship between miR-214 and age was identified by multiple 
regression.  
 
miR-214 modulates vascular TGF- in Ang II hypertension. 
 
To further understand the role of miR-214 in the regulation of perivascular fibrosis we studied the 
expression of Tgfb1 (TGF-) and fibronectin (FN1). While both TGF-and FN1 were induced in Ang II 
infused WT mice, only TGF- mRNA and protein induction were abolished in the aorta of miR-214-/- mice 
(Figure 3E and F), indicating indirect regulation of TGF- by miR-214. 
 
miR-214 regulates vascular dysfunction and perivascular inflammation in hypertension independently of 
blood pressure. 
 
A strong link between miR-214 and vascular phenotype was further supported by correlations of 
plasma miR-214 with NO-dependent endothelial vascular function, measured by flow mediated dilatation 
(FMD), but not with the endothelium independent responses to nitroglycerine (NMD; Figure 4A). These 
observations in humans were corroborated in miR-214-/- mice, which were protected from the development 
of endothelial dysfunction, demonstrating preserved NO-mediated vasodilatation, in spite of Ang II induced 
hypertension (Figure 4B). No differences in non-endothelium dependent vasorelaxations to sodium 
nitroprusside were observed (Figure 4B). As eNOS is a predicted miR-214 target, changes of eNOS 
expression could explain alterations of endothelial function. However, in aortas of Ang II treated mice we 
did not observe changes in total eNOS protein, compared to miR-214-/- mice (Figure 4C). As oxidative 
stress is known to mediate both endothelial dysfunction and vascular stiffness in hypertension, we next 
investigated vascular superoxide production and Nox2 and Nox4 NADPH oxidases. MiR-214-/- mice 
showed reduced induction of vascular oxidative stress upon Ang II infusion, as measured by superoxide 
production (Figure 4D) and Nox2 NADPH oxidase mRNA and protein level (Figure 4E-F). These changes 
in vascular function and oxidative stress were accompanied by reduced perivascular recruitment of total 
leukocytes (Figure 5A) and CD3+ T cells (Figure 5B) in miR-214-/- hypertensive animals in comparison to 
hypertensive WT mice. Additionally, Ang II infusion significantly elevated the total number of 
macrophages and dendritic cells (CD11c+CD11b-) only in WT animals, but not in miR-214-/- mice (Figure 
5C). No significant changes were observed with respect to B cells or NK cells (Figure 5C).  
 
miR-214 induction in the T cells is essential for perivascular fibrosis. 
 
To further understand the mechanisms of the effects of miR-214 on vascular inflammation in 
hypertension, we next focused on the effects of hypertension on immune cell miR-214. In leukocytes 
isolated from both peripheral blood (PBMC) and PVAT we observed miR-214 induction only within CD3+ 
cells (T cells), and not in CD3 negative cells (Figure 5D). Furthermore, miR-214 did not increase in PVAT 
of RAG-1-/- mice, lacking mature T cells, despite Ang II infusion (Figure 5E). This further supports the 
hypothesis that infiltrating T cells are an essential source of the increase of miR-214 observed in PVAT.  
 
In keeping with the role of blood pressure elevation in miR-214 induction, miR-214 was not 
induced in T cells isolated from mice subjected to blood pressure-lowering with hydralazine and 
hydrochlorothiazide (Online Figure III). Moreover, we found that 24-hour stimulation of T cells using anti-
CD3 antibodies elevated miR-214 levels in vitro (Figure 5F). In contrast, stimulation of mouse primary 
fibroblasts and of primary VSMCs, endothelial cells or THP-1 monocytes in culture using Ang II or 
cytokine combinations did not significantly alter miR-214 expression level (Online Figure IV).  
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To understand the functional role of T cell miR-214 in hypertensive vascular remodeling, we 
performed adoptive transfer of either wild type or miR-214-/- T cells to RAG1-/- mice and studied 
perivascular fibrosis and collagen accumulation. We confirmed earlier findings of Wu et al.11 that RAG1-/- 
mice are protected from development of perivascular fibrosis and it is rescued by adoptive transfer of wild 
type T cells (Figure 6A-B). This effect was observed only when wild type, but not when miR-214-/- T cells 
were transferred (Figure 6A-B), while level of hypertension was similar irrespective of T cell miR-214 
status. This was accompanied by reduced aortic collagen expression in RAG1-/- transferred with miR-214-
/- T cell when compared to WT T cells (Figure 6C). Similar levels of peripherally reconstituted circulating 
T cells were found in RAG1-/- mice upon adoptive transfer of WT and miR-214-/- cells (Figure 6D). At the 
same time, we found more than a 5-fold reduction of cd3 mRNA in the PVAT after transfer of miR-214-/- 
T cells in comparison to WT T cell transfer  
(Figure 6E).  
 
MiR-214 and mineralocorticoid signaling. 
 
As mineralocorticoid signaling is important in modulation of both fibrosis and T cell function in 
hypertension22, we have investigated potential changes of mineralocorticoid signaling in T cells in miR-
214-/- mice. Plasma aldosterone levels were unaltered in miR-214-/- mice (Online Figure V A). Furthermore, 
upon Ang II infusion, there were no changes in either mineralocorticoid (MR) or glucocorticoid receptor 
(GR) mRNA or protein level in T cells (Online Figure V B-C). We also analyzed the effects of aldosterone 
on anti-CD3 dependent T cell fibrosis-related cytokine mRNA in vitro in WT and miR-214-/- T cells. 
Aldosterone induced only TGF-  mRNA in WT T cells, while other studied cytokines were not 
significantly induced. This induction was not observed in miR-214-/- mice (Online Figure V D). These 
studies show that MR signaling is unlikely to a play critical role in the effects of miR-214 on perivascular 
fibrosis. 
 
Transcriptional profiling reveals crucial role of miR-214 in hypertensive T cell activation. 
 
To understand how miR-214 in the T cell could modulate the pro-fibrotic T cell phenotype in 
hypertension, we performed RNASeq analysis of isolated splenic T cells from sham and Ang II infused 
WT and miR-214-/- mice. This analysis has shown that in vivo Ang II infusion induced at least a 2-fold 
change in 1380 genes in WT T cells, while miR-214-/- T cells remained greatly unresponsive with only 51 
genes altered (Figure 7A). Relevant gene sets significantly affected by Ang II hypertension in WT T cells 
included cytokine metabolic processes, leukocyte migration, leukocyte cell-cell adhesion, and the 
regulation of T cell activation. None of these were changed in miR-214-/- (Figure 7B). Only 19 of these 
genes overlapped between WT and miR-214-/- further emphasizing the extent of the reprogramming of 
hypertensive T cells by miR-214. This is also exemplified by diversity of genes which are significantly 
induced in WT but not in miR-214-/- T cells (Figure 7C; analysis using interaction term with FDR 
correction). Conversely, a large number of the top 50 genes significantly repressed in WT T cells, but not 
in miR-214-/- T cells were the predicted targets for this microRNA (Figure 7D), further supporting a 
pleiotropic role of miR-214 in transcriptional reprograming of T cells by Ang II.  
 
MiR-214 regulates T cell activation and chemotaxis in hypertension. 
 
Following the analysis of our RNASeq data, we next studied mRNA and protein levels of key pro-
inflammatory and profibrotic cytokines upon Ang II-induced hypertension. mRNA expression was studied 
in activated T cells isolated from spleens of sham and Ang-II infused WT or miR-214-/- mice. As expected, 
Ang II hypertension caused increased induction of Il17a, Tgfb1 Tnfa, Il9, Ccl5, and Ifngin the WT T cells. 
MiR-214-/- mice were protected from this induction (Figure 8A). The effects of miR-214 on the induction 
of T cell protein levels of IL-17, TNF- , Il-9 and IFN- in vivo, were confirmed by intracellular staining 
using flow cytometry (Figure 8B). 
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Chemokine dependent perivascular recruitment of T cells is essential for vascular dysfunction19 
and aortic stiffening11. In order to further investigate this phenomenon, we studied expression of relevant 
chemokine receptors in normotensive and hypertensive WT and miR-214-/- mice. We observed induction 
of CCR1, CCR2, CCR4, CCR5, and CCR6 as well as CXCR3 on the surface of T cells in Ang II 
hypertension (Figure 8C). These increases were not observed in miR-214-/- mice (Figure 7C), suggesting 
that reduced chemotaxis of these cells can explain decreased T cell recruitment in miR-214-/- mice. 
Therefore, we next investigated the role of miR-214 in the regulation of T cell chemotaxis in vitro using 
the Boyden chamber and in vivo air-pouch experiments (Figure 8D-E). Peripheral blood T cells from the 
miR-214-/- mice infused with Ang II exhibited reduced chemotaxis towards key chemokines involved in 
hypertension - CCL5 and CXCL10 when compared to WT mice (Figure 8D). This observation was 
confirmed using an in vivo chemotaxis model, in which T cell recruitment into the air-pouch wall was 
inhibited by miR-214-/- in Ang II-hypertensive mice (Figure 8E).  
 
 
 
DISCUSSION 
 
We have identified the role of miR-214 in mediating perivascular fibrosis in hypertension. We link 
these pathophysiological effects of elevated miR-214 to the T cell compartment that infiltrates the PVAT 
and induces the fibrotic response. MiR-214, affects global change of transcriptomic profile in T cells in 
hypertension, enabling their activation and recruitment into perivascular fat. It also regulates the 
development of T cell pro-fibrotic properties in hypertension. These mechanistic studies in mice, led us to 
show in humans that plasma miR-214 is increased in hypertension, and is significantly associated with 
pulse wave velocity and endothelial dysfunction in hypertensive subjects. Hence, miR-214 is a new target 
linking the T-cell inflammatory cascade to vascular complications of hypertension. 
 
While our study is the first to link miR-214 to vascular dysfunction and perivascular fibrosis, earlier 
studies have shown that miR-214 regulates cardiac and renal fibrosis in the conditions of organ-selective 
stress. MiR-214 repression is protective in the setting of unilateral ureteral obstruction (UUO)-induced renal 
fibrosis and damage, but at the same time miR-214 loss exacerbates cardiac fibrosis evoked by ischemia-
reperfusion injury13. Those studies indeed highlight the organ-specific context in which miRNAs can drive 
opposing responses, presumably due to the different cell types, in which the miRNA is expressed in and 
the cell-specific transcriptome induced in response to different pathogenic stimuli.  
 
We report that miR-214-/- mice are protected from the development of endothelial dysfunction, a 
hallmark of hypertension23, despite the similar blood pressure response to Ang II. While this might be 
regulated by the role of miR-214 in the endothelium itself, we have previously shown that T cell infiltration 
into the vessel wall induces  endothelial dysfunction mainly through IFN-gamma dependent mechanisms19. 
In line with these observations, miR-214-/- prevented T cell activation and IFN- release.  
 
The mechanisms through which T cells and their cytokines such as IL-17, IFN-, TNF- and TGF-
 can affect perivascular fibrosis have been previously demonstrated24-28. In our model TGF- appears to 
be the most evident regulator of fibrosis in aortas from Ang II hypertensive mice. Its induction is alleviated 
in miR-214-/- mice, even though TGF- is not a direct target of miR-214. This effect may however be 
explained by the fact that TGF- expression in fibroblasts may be induced by T cell derived cytokines, such 
as IFN-, TNF- or IL-1724. 
 
Induction of miR-214 in PVAT and T cells is dependent on blood pressure increases, rather than 
by direct actions of Ang II. This is in line with earlier observations that T cell activation and vascular 
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recruitment depend on pressure increase and are in part dependent on mechanical stretch11, that involves 
and affects antigen presenting cell activation29. Taking into account that miR-214 increases in T cells upon 
activation and perivascular T cell infiltration increases 3-4 fold in hypertension, T cell infiltration into 
PVAT may provide the most compelling mechanism of miR-214 increase in this compartment in Ang II 
induced hypertension. Moreover, miR-214 appears to regulate T cell activation characterized by profibrotic 
effector cytokine production and chemokine receptor expression. The mechanisms of this are complex and 
not fully understood. RNASeq analysis of isolated T cells showed that Ang II causes profound 
transcriptional changes, which are lost in miR-214-/- T cells. It is difficult to molecularly dissect a single 
repressor of T cell activation and migration that could be responsible for the effects of miR-214. RNASeq 
suggested that miR-214 in the T cells has a broad pleotropic effect, leading to global change in T cell 
activation in hypertension. The combined effect of these alterations is likely responsible for the beneficial 
phenotypic changes in hypertension. Further studies are needed to fully understand all the pathways central 
to these effects orchestrating vascular inflammation and stiffness and to develop possible selective 
therapeutic targeting approaches.  
 
While our study shows the role of miR-214 in T cell activation and cytokine production in 
hypertension for the first time, one should be cautious in attempts to apply these findings to other 
inflammatory conditions. For example, miR-214 decreases in relapsing phase of multiple sclerosis, which 
is accompanied by increased Th17 cells18.  
 
Interestingly, we observe that the induction of major hypertensive cytokines is inhibited in T cells 
from Ang II-infused miR-214-/- mice, but no effects on blood pressure responses was seen in this model. 
This is surprising but may reflect a complex role of cytokines at different stages of hypertension, as well as 
a possible differential role of vascular and renal inflammation at different stages of hypertension. In fact, 
our blood pressure data are in contrast to very recent suggestions that intra-renal application of antagomir 
targeting miR-214-3p significantly attenuated salt-induced hypertension and albuminuria in SS rats. miR-
214-3p directly targeted eNOS in Dahl salt-sensitive rats16. However, in our model we did not see decreases 
in eNOS expression in the vessels upon Ang II infusion. This discrepancy may be related to different model 
of hypertension used. Congenic Dahl salt-sensitive rat used in that study is primarily kidney-dependent30, 
which may contribute to observed difference. Interdependence with other immune cells involved in 
hypertension, such as B cells31, macrophages32 and NK cells33 should be considered as well. While our 
studies do not show miR-214 induction in non-T cell immune cells, their role may be upstream from the T 
cell in immune activation33. 
 
Finally, it is important to note that we reported that miR-214 is increased in plasma of hypertensive 
patients and is linked to pulse wave velocity as a measure of vascular stiffening in humans34. Thus, miR-
214 might serve as a valuable biomarker of vascular stiffening. Moreover, considering the pivotal role of 
miR-214 in regulating vascular inflammation, endothelial dysfunction, oxidative stress and perivascular 
fibrosis, all constituting elements of accelerated vascular ageing, our study indicates a possibility of the use 
of miR-214 as a biomarker of accelerated vascular ageing and in the future targeting T cell miR-214 to 
target this important process. Our studies also emphasize the need to identify novel therapies inhibiting T 
cell activation and their recruitment in cardiovascular diseases35, 36. 
 
In summary, we have identified that miR-214 is an essential regulator of T cell dependent 
mechanisms of vascular stiffening, fibrosis and dysfunction in hypertension. It may represent a novel 
biomarker and a possible target for modulation of perivascular inflammation.  
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FIGURE LEGENDS 
 
Figure 1: MiR-214 is increased in the vasculature and immune cells in Ang II induced hypertension.    
A. Principal component analysis of miRs in PVAT (top) and volcano plot (bottom) in sham and Ang II 
treated mice. B. Heatmap presenting z-scores calculated from individual miR -ΔCt values of all miRs 
significantly altered (t-test FDR adj p<0.05; n=5-6). C. Levels of miR-214/199 cluster (top) and pri-miR-
214 (bottom) in PVAT (n=4-9). D. In situ hybridization of miR-214 in the vascular wall. Scale bar=300𝜇m. 
E. Levels of miR-214 in isolated PVAT, vessel wall layers (n=3 replicates of 3 pulled mice – 9 mice/group), 
kidney and selected immune organs (n=3-6). F. Levels of miR-214 and pri-miR-214 in PVAT of mice 
treated with placebo (PBO) or hydralazine/hydrocholrothiazide (Hyd/HCT) (n=6/group). Data presented as 
mean±SEM; t-test with FDR correction (Panel C-p values adjusted for 4 comparisons; miR clusters; panel 
E- p, adjusted for 8 comparisons; various organs) or by two-way ANOVA (for miR-214 level; pAngII x 
Drug=3.7e-06, pAngII=4.3e-07, pDrug=1.4e-05; for pri-miR-214 level; pAngII x Drug=0.018, pAngII=1.2e-03, 
pDrug=0.12) with Tukey’s multiple comparisons test (panel F; p-values adjusted for 6 comparisons). 
 
Figure 2: Pivotal role of miR-214 in the regulation of perivascular fibrosis in Ang II dependent 
hypertension.    A. Tail-cuff BP in sham and Ang II infused miR-214-/- and WT littermates (n=9/group).  
B. Systolic BP measured by telemetry at baseline and during Ang II infusion (average, left; example 
readings, right; n=5). C. Perivascular collagen accumulation in picrosirius red (top) and Masson’s trichrome 
(bottom) staining (representative of n=9; scale bar=300𝜇m). D. Quantitative analysis of perivascular 
collagen deposition in Masson trichrome (n=9/group). E. Collagen 1, 3 and 5 mRNA in miR-214-/- and WT 
littermates infused with buffer or Ang II (n=11/group). F. Aortic collagen quantification by hydroxyproline 
assay (n=7 in Sham and n=9 in Ang II). Data presented as mean±SEM; repeated measures two-way 
ANOVA (Panels A-B), Kruskal-Wallis test with FDR correction (Panels D and F; p-values adjusted for 6 
comparisons) or two-way ANOVA with Tukey’s test (Panels E; p-values adjusted for 6 comparisons). 
Overall p values for repeated measures two-way ANOVA; Panel A (pTime=0.0051, pGroup=1.8e-08,  
pTime x Group=0.1378); Panel B (pGroup=0.06, pTime=2.6e-07, pGroup x Time=0.83); for two-way ANOVA; Panel E 
for Col1a1 (pAngII x Genotype=0.003, pAngII=1.3e-05, pGenotype=0.0035), Col3a1 (pAngII x Genotype=0.037, 
pAngII=0.0034, pGenotype=0.033) Col5a1 (pAngII x Genotype=0.028, pAngII=0.0053, pGenotype=0.042), for Kruskal-
Wallis; Panel D (p=0.0003) and Panel F (p=0.0006). 
 
Figure 3: Role of miR-214 in the regulation of vascular stiffening in mouse and human hypertension 
A. Thoracic aorta stiffness studied by pressure myography (n=5-8). B. Elastic modulus of adventitial 
stiffness measured by atomic force microscopy (right) with representative force-indentation curves (left) 
(n=5-6/group).  C. Circulating miR-214 serum levels in normotensive (Ctr, n=49) and hypertensive (HTN, 
n=51) patients. D.  Correlation between plasma miR-214 levels and pulse wave velocity (PWV) in humans 
with and without hypertension (n=100). E. TGF- and fibronectin mRNA expression in control and 
hypertensive miR-214-/- and WT mice (n=4-9/group). F. Protein level of TGF- and fibronectin in aortas 
studied by WB (n=5-9). Data presented as mean±SEM repeated measures two-way ANOVA with 
Bonferroni correction (Panel A), Kruskal-Wallis test with FDR correction (Panel B; p-adjusted for 6 
comparisons) or two-way ANOVA with Tukey’s test (Panels E and F; p-values adjusted for 6 comparisons) 
or t-test (Panel C). Spearman’s rank test was used to assess correlations (Panel D). Overall p values for two-
way ANOVA; Panel A (pAngII=1.8e-05, pGenotype=0.042), pAngII x Genotype=0.097), Panel E for Tgfb1 (pAngII x 
Genotype=0.0059, pAngII=0.0031, pGenotype=0.225), FN1 (pAngII=1.2e-05, pGenotype=0.266, pAngII x Genotype=0.218); 
Panel F for TGF- (pAngII x Genotype=0.0034, pAngII=5.1e-07, pGenotype=0.0087), for FN1 (pAngII=0.0015, 
pGenotype=0.243), pAngII x Genotype=0.589) and Kruskal Wallis  Panel B (p=0.0368). 
 
Figure 4: Essential role of miR-214 in endothelial dysfunction and vascular oxidative stress in 
hypertension. A. Relationship between plasma miR-214 levels and endothelial function (Flow Mediated 
Dilatation; FMD) or non endothelium dependent relaxations to nitroglycerin (NMD) in humans (n=100). 
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B. Isometric tension studies of  endothelium dependent (acetylcholine; ACh) and independent (sodium 
nitroprusside; SNP) vasorelaxations (n=5-7/group) using wire myography in sham buffer and Ang II 
infused WT and  
miR-214-/- mice C. eNOS protein level in mouse aortas (Western blotting; n=9-12/group). D. Aortic 
superoxide production measured by lucigenin (5M) enhanced chemiluminescence (n=7-9/group). E. 
Aortic Nox2 and Nox4 mRNA expression (n=5/group) and (F) protein levels in aortas of sham and Ang II 
infused miR-214-/- and WT mice. (n=9-12/group). Data presented as mean±SEM and analysed by 
Spearman’s rank correlation test (panel A), repeated measures two-way ANOVA with Bonferroni 
correction (Panel B) or two-way ANOVA with Tukey’s post-hoc test (Panel C-F; p-values adjusted for 6 
comparisons). Overall p values for repeated measures two-way ANOVA; Panel B for Ach (pResponse=0.0009, 
pGroup=0.044, pResponse x Group=0.016) and SNP (pResponse=04.1e-07, pGroup=0.049), pResponse x Group=0.217). Two-
way ANOVA; Panel C (pAngII=0.949, pGenotype=0.862, pAngII x Genotype=0.235), Panel D (pAngII x Genotype=0.061, 
pAngII=0.0042, pGenotype=0.051), Panel E for Nox2 (pAngII x Genotype=0.0062, pAngII=0.193, pGenotype=0.203), for 
Nox4 (pAngII x Genotype=0.331, pAngII=0.002, pGenotype=0.005); Panel F for Nox2 (pAngII=0.0096, pGenotype=0.683, 
pAngII x Genotype=0.116) and Nox4 (pAngII=0.0093, pGenotype=0.924, pAngII x Genotype=0.109). 
 
Figure 5. Crucial role of miR-214 in regulation of perivascular inflammation in hypertension.   
A. Total number of leukocytes and T cells (B) with representative density plots (n=6-9/group). C. Number 
of perivascular macrophages (F4/80+), dendritic cells (CD11c+), B cells (B220+) and NK cells (NK1.1+) 
per mg of tissue, studied by flow cytometry (n=5-7/group). Data presented on volcano plots depicting 
median(__) and quartiles(….). D. miR-214 induction in T cells (CD3+) and remaining leukocytes (CD3-) in 
Ang II hypertension measured in cells from peripheral blood (left, PBMC n=5-6/group) and from PVAT 
(right, n=3/group of 3 pulled mice). E. MiR-214 level in PVAT of WT and RAG1-/- animals (n=5-7/group). 
F. miR-214 in quiescent (direct lysis; control mAb) and anti-CD3 mAb activated T cells (n=3-4/group). 
Data presented as mean±SEM and analyzed by Kruskal-Wallis test (Panels A-C), two-way ANOVA with 
Tukey’s post-hoc test (Panel D; p-values adjusted for 6 comparisons), t-test (E) and by Kruskal-Wallis test 
with FDR (F; p-values adjusted for 3 comparisons). Overall p values for Kruskal-Wallis; Panels A 
(p=0.017), B (p=0.011), C (p=0.06), D (p=0.05) and F (0.0001); two-way ANOVA; Panel D for PBMC 
(pCD3 x AngII=0.0006, pAngII=0.0026, pCD3=0.0006) and PVAT(pAngII=0.024, pCD3=0.115, pCD3 x AngII=0.115). 
 
Figure 6. T cell miR-214 mediates perivascular fibrosis and pro-fibrotic T cell accumulation in PVAT 
in Ang II induced hypertension.  A. Vascular collagen accumulation in response to Ang II-hypertension 
assessed using picrosirius red (left) and Masson’s trichrome (right; scale bar=300𝜇m, representative of n=4-
5/group) with quantification of adventitial collagen (B) in RAG1-/- mice and upon adoptive transfer of WT 
and miR-214-/- T cells (n=4-5/group). C. Ang II dependent induction of Col 1, 3 and 5 mRNA in aortas of 
RAG1-/- transferred with WT or  
miR-214-/- T cells (n=4-5). D. Levels of circulating T cells in RAG1-/- mice and upon adoptive transfer of 
WT or miR-214-/- T cells (left) with representative dot plots (right; n=4-5/group). E. CD3 mRNA in PVAT 
of RAG1-/- mice and upon adoptive transfer of WT or miR-214-/- T cells (n=4-5/group). Data presented as 
mean±SEM and analyzed by one-way ANOVA with Tukey’s post-hoct test (Panels B, D, E; p-values 
adjusted for 6 comparisons), t-test with FDR (Panel C; p-values adjusted for 3 comparisons). Overall p 
values for one-way ANOVA; Panel B (p=6.3e-05), D (p=1.5e-08) and E (p=7.8e-06). 
 
Figure 7: Essential role of miR-214 in T cell responses in Ang II induced hypertension. A. Genes with 
absolute log2FC>1, significantly (FDR adj p <0.05 calculated using Wald test in DESeq2) changed in T 
cells following 2-weeks AngII infusion in vivo in WT (left) and mir214-/- (right) mice (n=3). Venn diagram 
indicates total numbers of genes changed in each strain of mice in response to Ang II. B. Top 30 pathways 
significantly upregulated in WT T cells following 2-weeks AngII infusion in vivo in WT mice. C. Top 50 
genes (based on interaction term estimate) preferentially induced by Ang II infusion in WT when compared 
to mir214-/- mice (FDR adj pinteraction<0.05 for all presented) D. Top 50 genes preferentially repressed by 
AngII infusion in WT as compared to miR-214-/- mice. Predicted targets of miR-214 for miRWalk (# red) 
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and TargetScan 7.1 (# green). Data on heat maps are presented as z-scores of log transformed, normalized 
gene read counts (Log NRC) calculated with DESeq2.  
 
Figure 8: MiR-214 modulates T cell pro-inflammatory cytokine production, chemokine receptors 
expression and T cells migration in Ang II induced hypertension.  A. Heatmap of selected profibrotic 
cytokine mRNA in T cells upon Ang II induced hypertension in WT (left) and miR-214-/- (right) mice. Gene 
expression was studied upon ex vivo activation by anti-CD3 and anti-CD28 for 24hours (n=3-4/group) and 
presented as fold change, relative to average of sham. B. Cytokine production by T cells in sham buffer and 
Ang II infused WT and mir214-/- mice (n=4-6/group) upon 6h stimulation with PMA studied by flow 
cytometry. C. T cell chemokine surface receptors in sham and Ang II-infused WT and mir214-/- mice 
studied by flow cytometry with representative histograms (n=4-6/group). D. In vitro chemotaxis of T cells 
obtained from hypertensive animals towards CXCL10 and CCL5 in Boyden chambers (n=6/group) with 
representative dot plots reflecting control and chemokine induced migration. E. Air pouch model of T cell 
chemotaxis (top) showing T cell recruitment toward membranes surrounding air-pouch filled with 
carrageenan and recombinant proteins (CXCL10 and CCL5) in hypertensive WT and miR-214-/- mice with 
representative density plots (n=3-4/group). Data presented as mean±SEM and analysed by t-test with FDR 
(All genes show FDR adj p<0.05 in WT but not in miR-214-/-), Mann-Whitney U test (Panel D) or t-test 
(Panel E). Two-way ANOVA with Tukey’s (Panel B-C; p-values adjusted for 6 comparisons). Overall p 
values for two-way ANOVA; Panel B for IFN (pAngII x Genotype=0.0073, pAngII=0.0068, pGenotype=0.0988), TNF 
(pAngII x Genotype=0.0475, pAngII=0.0001, pGenotype=0.0042), IL17a (pAngII=0.0007, pGenotype=0.1316, pAngII x 
Genotype=0.0814) and IL9 (pAngII=0.0045, pGenotype=0.0245, pAngII x Genotype=0.0994); Panel C for CCR1 (pAngII x 
Genotype=0.0413, pAngII=0.0198, pGenotype=0.2508), CCR2 (pAngII x Genotype=0.0467, pAngII=0.0452, 
pGenotype=0.1193), CCR4 (pAngII x Genotype=0.0081, pAngII=0.0022, pGenotype=0.0013), CCR5 (pAngII x 
Genotype=0.0142, pAngII=0.0047, pGenotype=0.0186), CCR6 (pAngII x Genotype=0.0445, pAngII=0.0066, 
pGenotype=0.0596), CXCR3 (pAngII=0.0167, pGenotype=0.0771, pAngII x Genotype=0.163). 
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NOVELTY AND SIGNIFICANCE 
 
What Is Known? 
 
 Hypertensive vascular stiffening, characterized by perivascular fibrosis, is a determinant of 
accelerated vascular aging and predictor of cardiovascular morbidity and mortality.  
 
 Perivascular fibrosis is mediated by immune cell infiltration and linked to Th17 lymphocytes. 
 
 miR-214 is important in regulating cardiac and renal fibrosis and is expressed by immune cells.  
 
 
What New Information Does This Article Contribute? 
 
 miR-214 is increased in perivascular adipose tissue (PVAT) in hypertension, and this increase is 
observed primarily in T cells infiltrating the vessel. 
 
 MiR-214 expression in T cells enables their activation and recruitment into perivascular fat in 
hypertension. MiR-214 also regulates T cell pro-fibrotic properties in response to pro-hypertensive 
stimuli. 
 
 T cell MiR-214 is required for perivascular fibrosis, vascular stiffening, and endothelial 
dysfunction in Ang II hypertension. 
 
 Plasma miR-214 is increased in patients with hypertension and directly correlated to pulse wave 
velocity and endothelial function. 
 
Hypertension is associated with vascular stiffening, measured by pulse wave velocity, which is a predictor 
of cardiovascular morbidity and mortality. As perivascular inflammation and perivascular fibrosis are 
hallmarks of hypertensive vasculopathy, we aimed to identify molecular microRNA regulators of these 
processes. Out of 381 miRs screened in the vascular tissues in response to angiotensin II-mediated 
hypertension, miR-214 showed the highest induction, localizing primarily to perivascular adipose tissue. 
MiR-214-/- mice were protected from Ang II-induced periaortic fibrosis, induction of collagens and vascular 
stiffening independently of blood pressure responses. Using a model of adoptive transfer of T cells into 
RAG1-/- mice, we have shown a key role of T cell-derived miR-214 in this process. Looking at T cells by 
RNASeq we observed that Ang II-induced hypertension caused a significant change in the expression of 
1380 T cell genes in wild-type mice, but only 51 in miR-214-/-. T cell activation, proliferation and 
chemotaxis pathways were differentially affected. This manifested in reduced in vitro and in vivo T cell 
chemotaxis resulting in attenuation of profibrotic perivascular inflammation. Finally, we show that plasma 
miR-214 is increased in patients with hypertension and is correlated to pulse wave velocity (vascular 
stiffness) and flow-mediated dilatation (endothelial dysfunction). We propose that miR-214 regulates 
vascular function and may be an important biomarker and possibly future therapeutic target in perivascular 
fibrosis.  
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